Spots Global Cancer Trial Database for gist tyrosine kinase inhibitor
Every month we try and update this database with for gist tyrosine kinase inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST | NCT03465722 | GIST | avapritinib regorafenib | 18 Years - | Blueprint Medicines Corporation | |
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) | NCT05160168 | Gastrointestina... Neoplasms, Conn... Neoplasms, Conn... Neoplasms by Hi... Neoplasms Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... | THE-630 | 18 Years - | Theseus Pharmaceuticals | |
(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors | NCT02508532 | Gastrointestina... Other Relapsed ... | Avapritinib | 18 Years - | Blueprint Medicines Corporation | |
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST | NCT03465722 | GIST | avapritinib regorafenib | 18 Years - | Blueprint Medicines Corporation |